Summary
63.30 -0.50(-0.78%)07/17/2025
CVS Health Corporation (CVS)
CVS reported last earnings on 2025-05-01 after the market. An EPS of $2.25 was observed compared to an estimated EPS of $1.7, resulting in a surprise value of $0.55. A revenue of $94,588 million was observed compared to an estimated revenue of $93,679 million, resulting in a surprise value of $909 Million.
CVS Health Corporation (CVS)
Key Facts
1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years |
-2.18 | -2.28 | -5.65 | -4.95 | 23.08 | 7.51 | 16.15 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan!
Fundamental Ratings
Category | Rating |
Main Rating | B+ |
Recommended Rating | Neutral |
DCF | Strong Buy |
ROE | Neutral |
ROA | Neutral |
Debt/Equity | Strong Sell |
P/E | Sell |
P/B | Buy |
Earnings
Trading Data | ||
Close | 61.92 | |
Open | 63.35 | |
High | 63.41 | |
Low | 61.50 | |
Volume | 6,857,684 | |
Change | -1.38 | |
Change % | -2.18 | |
Avg Volume (20 Days) | 6,921,445 | |
Volume/Avg Volume (20 Days) Ratio | 0.99 | |
52 Week Range | 42.73 - 72.51 | |
Price vs 52 Week High | -14.60% | |
Price vs 52 Week Low | 44.89% | |
Range | 0.00 | |
Gap Up/Down | -1.46 |
Profitibility | ||
Market Capitalization (Mln) | 84,845 | |
Revenue per share | 300.5234 | |
Net Income per share | 4.1872 | |
Dividend Yield | 0.0420 | |
Dividend Share | 266.00% | |
Valuations | ||
Enterprise Value | 0.00% | |
PE Ratio | 15.1177 | |
PB Ratio | 0.0000 | |
PTB Ratio | 0.0000 | |
Liquidity | ||
Debt/Equity Ratio | 0.0000 | |
Net Debt/EBIDTA Ratio | 0.0000 | |
Current Ratio | 0.0000 |
Enterprise Value and Cash Flow | ||
EV/Sales Ratio | 0.0000 | |
EV/EBIDTA Ratio | 0.0000 | |
EV/Free Cash Flow Ratio | 0.0000 |
07/18 10:30 EST - zacks.com
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Is CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
07/18 09:36 EST - zacks.com
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
CVS Health's Caremark to Lead CalPERS' PBM Vision: What's at Stake?
CVS wins a major CalPERS deal as Caremark replaces OptumRx, backed by $250M in performance guarantees and drug cost controls.
07/17 13:37 EST - https://www.patch.com
Dog Left In Hot Car Dies, Milford Man Charged: Police
MILFORD, CT — A Milford man is facing accusations that he left two dogs inside a car, which led to the death of one of the dogs, according to a police arrest log. John Torres, 72, was charged with two counts of cruelty to animals. Torres turned himself in on an active arrest warrant on July 10....
Dog Left In Hot Car Dies, Milford Man Charged: Police
MILFORD, CT — A Milford man is facing accusations that he left two dogs inside a car, which led to the death of one of the dogs, according to a police arrest log. John Torres, 72, was charged with two counts of cruelty to animals. Torres turned himself in on an active arrest warrant on July 10....
07/17 07:10 EST - seekingalpha.com
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth...
Most Managed Care Insurers Expected To See Q2 2025 Drops In Revenue, Net Income
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2, according to an S&P Global Market Intelligence analysis of sell-side analyst forecasts. Of the eight largest publicly traded US managed care insurers, all but two — UnitedHealth...
07/16 16:39 EST - seekingalpha.com
CVS Health - Q2 Earnings Are A Referendum On Future Of Company
CVS has transformed from a retail pharmacy to a complex healthcare conglomerate, but its stock price has remained stagnant over the past decade. The Medicare Advantage business, once seen as a growth engine, has become less profitable, leading to management shakeups and activist investor...
CVS Health - Q2 Earnings Are A Referendum On Future Of Company
CVS has transformed from a retail pharmacy to a complex healthcare conglomerate, but its stock price has remained stagnant over the past decade. The Medicare Advantage business, once seen as a growth engine, has become less profitable, leading to management shakeups and activist investor...
07/16 10:20 EST - zacks.com
4 Value Stocks to Buy as Inflation and Market Volatility Rise
CVS Health, Hudbay Minerals, Universal Health Services and ASB stand out as value stocks amid rising inflation.
4 Value Stocks to Buy as Inflation and Market Volatility Rise
CVS Health, Hudbay Minerals, Universal Health Services and ASB stand out as value stocks amid rising inflation.
07/16 10:01 EST - zacks.com
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
07/15 19:59 EST - wsj.com
CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal
CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers.
CVS Beats Out UnitedHealth for Calpers Pharmacy Benefits Deal
CVS Health's Caremark business signed a new pharmacy benefits contract with the California Public Employees' Retirement System, known as Calpers.
07/14 16:01 EST - zacks.com
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
07/10 08:00 EST - globenewswire.com
EngageWell, Rocket Doctor, and CVS Health Foundation Launch Virtual Healthy Aging Program for Adults over 60
Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide personalized follow-up support and connect patients to local resources The program is now available...
EngageWell, Rocket Doctor, and CVS Health Foundation Launch Virtual Healthy Aging Program for Adults over 60
Health checks include assessments for heart health, memory, cognitive function, and mental health No travel required — all appointments are virtual and confidential Community Health Workers provide personalized follow-up support and connect patients to local resources The program is now available...
07/09 10:41 EST - zacks.com
Here's Why CVS Health (CVS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why CVS Health (CVS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
07/09 09:15 EST - zacks.com
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?
CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.
Is CVS Moving Closer to Reaching Its Long-Term Low 3X Leverage Goal?
CVS Health inches closer to its long-term leverage target, helped by Aetna margin recovery and disciplined cash use.
07/08 12:06 EST - https://www.patch.com
Opening Date Announced For New Target Store In Guilford
GUILFORD, CT — After months of anticipation, an opening date has been announced for the new Target store at 900 Boston Post Road in Guilford. According to the company, the Guilford store will open on Aug. 17. A new Target will also open on that date in Norwalk at 680 Connecticut Ave. Hours in...
Opening Date Announced For New Target Store In Guilford
GUILFORD, CT — After months of anticipation, an opening date has been announced for the new Target store at 900 Boston Post Road in Guilford. According to the company, the Guilford store will open on Aug. 17. A new Target will also open on that date in Norwalk at 680 Connecticut Ave. Hours in...
07/07 09:56 EST - zacks.com
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
07/07 09:39 EST - prnewswire.com
CVS Health declares quarterly dividend
WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
CVS Health declares quarterly dividend
WOONSOCKET, R.I. , July 7, 2025 /PRNewswire/ -- CVS Health® (NYSE: CVS) has announced that its board of directors has approved a quarterly dividend of sixty-six and one-half cents ($0.665 cents) per share on the Common Stock of the Corporation.
07/04 09:45 EST - zacks.com
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu...
Can CVS Sustain Pharmacy & Consumer Wellness Gains Through Year-End?
CVS Health's CVS Pharmacy and Consumer Wellness (“PCW”) segment has seen steady growth in recent months, with revenues up 11.1% year over year in the first quarter of 2025. Performance was supported by seasonal trends, including the impact of high vaccine demand and a longer-than-usual flu...
07/03 08:03 EST - benzinga.com
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
07/02 18:46 EST - zacks.com
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.
07/02 13:11 EST - zacks.com
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.